Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02162225Phase 2Withdrawn
Phase 2, open-label, single-arm trial, sponsored by Wake Forest University Health Sciences. Primary endpoint: Total Number of Participants with Adverse Events up to 58 Days. Planned start Sep 2014; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02162225.